Hybrid nanocarriers incorporating mechanistically distinct drugs for lymphatic CD4+ T cell activation and HIV-1 latency reversal. [PDF]
Cao S +10 more
europepmc +1 more source
HIVGKO: A Tool to Assess HIV-1 Latency Reversal Agents in Human Primary CD4+ T Cells. [PDF]
Battivelli E, Verdin E.
europepmc +1 more source
Dendritic cells as natural latency reversing agent: A wake-up call for HIV-1 [PDF]
van Montfort, T. +2 more
openaire +2 more sources
Rapamycin-mediated mTOR inhibition uncouples HIV-1 latency reversal from cytokine-associated toxicity. [PDF]
Martin AR +5 more
europepmc +1 more source
Integration site-independent enhancement of latency reversal by HIV-1 Nef
X.T. Kuang +3 more
openaire +2 more sources
Novel use of alprazolam as a potential HIV-1 latency reversing agent
W. Elbezanti +4 more
openaire +2 more sources
O3 Heme-arginate as a latency-reversing agent for HIV-1 cure
Michaela Madlenakova +6 more
openaire +2 more sources
Targeted HIV-1 Latency Reversal Using CRISPR/Cas9-Derived Transcriptional Activator Systems. [PDF]
Bialek JK +7 more
europepmc +1 more source
Targeting NF-κB signaling for HIV latency reversal: Mechanisms, challenges, and therapeutic perspectives. [PDF]
Shirazi MMA, Sadat SM.
europepmc +1 more source
Kinetics of HIV-1 Latency Reversal Quantified on the Single-Cell Level Using a Novel Flow-Based Technique. [PDF]
Martrus G +7 more
europepmc +1 more source

